Market Vectors Biotech ETF (NYSEArca: BBH)
January Gain: 9.7%
Comment: Those that have been following the biotech industry since the start of the year probably are not surprised to see BBH on this list. If not for a loss of about 1% on Friday, BBH would flirting with a January gain of almost 11%. Impressively, that comes after a 2013 in which the ETF was locked in an intense battle to be the best non-leveraged health care ETF. [Intense Duel to be 2013’s Best Health Care ETF]